Share on LinkedInShare on LinkedIn

ARTICLE · 04 JANUARY 2018

PMPRB Releases Scoping Paper Relating To Proposed Amended Regulations

As previously reported, on December 2, 2017, Canada's Governor-in-Council published proposed Regulations Amending the Patented Medicines Regulations for comment.

CanadaIntellectual Property

As previously reported, on December 2, 2017, Canada's Governor-in-Council published proposed Regulations Amending the Patented Medicines Regulations for comment. On December 11, 2017, the Patented Medicine Prices Review Board (PMPRB) released the PMPRB Guidelines Scoping Paper – High Level Overview of Potential New Framework (Canada Gazette, Part I). According to the paper, the purpose is to provide a non-binding outline of preliminary thoughts on how to best operationalize the proposed changes, and is to be read in conjunction with the proposed amendments and Regulatory Impact Analysis Statement.

The scoping paper describes the framework as a risk-based approach to pricing review that is broken down into five main parts:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from